HAP Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-24,620
| Closed | -$2.73M | – | 884 |
|
|
2025
Q2 | $2.73M | Buy |
+24,620
| New | +$2.62M | 0.26% | 64 |
|
|
2023
Q2 | – | Sell |
-24,561
| Closed | -$1.96M | – | 1203 |
|
|
2023
Q1 | $2.04M | Sell |
24,561
-35,818
| -59% | -$2.97M | 0.32% | 76 |
|
|
2022
Q4 | $5.18M | Sell |
60,379
-103,794
| -63% | -$8.22M | 0.53% | 48 |
|
|
2022
Q3 | $10.1M | Buy |
164,173
+104,432
| +175% | +$6.59M | 0.68% | 32 |
|
|
2022
Q2 | $3.69M | Sell |
59,741
-30,104
| -34% | -$1.86M | 0.18% | 108 |
|
|
2022
Q1 | $5.34M | Sell |
89,845
-155,767
| -63% | -$9.96M | 0.22% | 76 |
|
|
2021
Q4 | $17.8M | Buy |
245,612
+9,781
| +4% | +$674K | 0.49% | 29 |
|
|
2021
Q3 | $16.5M | Buy |
235,831
+199,616
| +551% | +$14M | 0.54% | 24 |
|
|
2021
Q2 | $2.49M | Sell |
36,215
-17,141
| -32% | -$1.14M | 0.08% | 235 |
|
|
2021
Q1 | $3.45M | Sell |
53,356
-57,386
| -52% | -$3.7M | 0.18% | 109 |
|
|
2020
Q4 | $6.45M | Buy |
110,742
+40,244
| +57% | +$2.43M | 0.19% | 94 |
|
|
2020
Q3 | $4.46M | Buy |
+70,498
| New | +$4.89M | 0.22% | 78 |
|
|
2020
Q1 | – | Sell |
-148,528
| Closed | -$10.3M | – | 1312 |
|
|
2019
Q4 | $9.65M | Buy |
148,528
+7,565
| +5% | +$493K | 0.53% | 38 |
|
|
2019
Q3 | $8.93M | Sell |
140,963
-778
| -0.5% | -$50.9K | 0.73% | 28 |
|
|
2019
Q2 | $9.58M | Sell |
141,741
-7,285
| -5% | -$479K | 0.74% | 30 |
|
|
2019
Q1 | $9.69M | Buy |
+149,026
| New | +$9.91M | 0.86% | 30 |
|
|
2018
Q4 | – | Sell |
-38,520
| Closed | -$2.69M | – | 1187 |
|
|
2018
Q3 | $2.97M | Buy |
+38,520
| New | +$2.91M | 0.19% | 115 |
|
|
2018
Q1 | – | Sell |
-42,943
| Closed | -$3.41M | – | 1016 |
|
|
2017
Q4 | $3.08M | Buy |
+42,943
| New | +$3.26M | 0.13% | 129 |
|
|
2017
Q3 | – | Sell |
-23,291
| Closed | -$1.78M | – | 947 |
|
|
2017
Q2 | $1.65M | Sell |
23,291
-65,213
| -74% | -$4.34M | 0.09% | 194 |
|
|
2017
Q1 | $6.01M | Buy |
88,504
+74,818
| +547% | +$5.26M | 0.37% | 62 |
|
|
2016
Q4 | $980K | Buy |
+13,686
| New | +$1.02M | 0.05% | 253 |
|
|
2016
Q1 | – | Sell |
-112,107
| Closed | -$10.1M | – | 887 |
|
|
2015
Q4 | $11.3M | Buy |
+112,107
| New | +$11.7M | 0.55% | 36 |
|
|
2014
Q2 | – | Sell |
-32,298
| Closed | -$2.51M | – | 1030 |
|
|
2014
Q1 | $2.29M | Buy |
+32,298
| New | +$2.53M | 0.1% | 166 |
|
Other funds holding GILD
HAP Trading's GILD Position: Q3 2025 in Review
HAP Trading sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 24,620 shares — an estimated $2.73M sold.
HAP Trading first reported a position in GILD in Q1 2014 and held it in 23 quarters. The position peaked at $17.8M in Q4 2021. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- HAP Trading reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 24,620 Gilead Sciences shares in Q3 2025, an estimated $2.73M.
- HAP Trading first reported a position in Gilead Sciences in Q1 2014 and held it in 23 quarters.
- HAP Trading's Gilead Sciences position peaked at $17.8M in Q4 2021.
- 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.